PROVEXIS PLC — Investor Relations & Filings
Filings indexed
207
across all filing types
Latest filing
2026-05-20
Major Shareholding Noti…
Country
GB
United Kingdom
Listing
IL
PXS
Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-20 | English | |
| Half-year Financial Report | 2025-12-31 | English | |
| Result of AGM | 2025-11-21 | English | |
| Group of companies' accounts made up to 2025-03-31 | 2025-11-12 | English | |
| Final Results | 2025-10-30 | English | |
| Delay in publication of annual accounts | 2025-09-30 | English |
Browse filings by year
23 years- 2026 1 filing
- 2025 6 filings
- 2024 8 filings
- 2023 7 filings
- 2022 8 filings
- 2021 22 filings
- 2020 10 filings
- 2019 12 filings
- 2018 13 filings
- 2017 29 filings
- 2016 23 filings
- 2015 12 filings
- 2014 16 filings
- 2013 31 filings
- 2012 1 filing
- 2011 1 filing
- 2010 1 filing
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2004 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 46579349 | Holding(s) in Company | 2026-05-20 | English | ||
|
2025
6 filings
| |||||
| 11554037 | Half-year Financial Report | 2025-12-31 | English | ||
| 8501780 | Result of AGM | 2025-11-21 | English | ||
| 46820326 | Group of companies' accounts made up to 2025-03-31 | 2025-11-12 | English | ||
| 8062473 | Final Results | 2025-10-30 | English | ||
| 7939561 | Delay in publication of annual accounts | 2025-09-30 | English | ||
| 5562618 | Grant of Options and Warrants | 2025-01-07 | English | ||
|
2024
8 filings
| |||||
| 5560235 | Total Voting Rights | 2024-12-31 | English | ||
| 5560463 | Half-year Report | 2024-12-31 | English | ||
| 5556890 | Purchase of Fruitflow® II SD & royalty payment | 2024-12-18 | English | ||
| 5532742 | Result of AGM | 2024-10-25 | English | ||
| 46820328 | Group of companies' accounts made up to 2024-03-31 | 2024-10-11 | English | ||
| 5521115 | Final Results | 2024-09-30 | English | ||
| 5447930 | Total Voting Rights | 2024-04-30 | English | ||
| 5434160 | Issue of Equity - purchase of Fruitflow® II SD | 2024-03-28 | English | ||
Financials
Loading financials…
We couldn't load the financials
No data available yet
We have extracted financials for PROVEXIS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Asarina Pharma AB
A biotechnology company in liquidation, formerly focused on…
|
ASAP | SE | Professional, scientific and te… |
|
Atara Biotherapeutics, Inc.
Develops off-the-shelf allogeneic T-cell immunotherapies fo…
|
ATRA | US | Professional, scientific and te… |
|
ATUM CO., LTD.
An integrated biologics development partner offering servic…
|
355690 | KR | Professional, scientific and te… |
|
AUREKA LIMITED
Accelerates drug discovery and development using AI and com…
|
AKA | AU | Professional, scientific and te… |
|
Avalo Therapeutics, Inc.
Clinical-stage biotech developing treatments for immune-med…
|
AVTX | US | Professional, scientific and te… |
|
Avalyn Pharma Inc.
Developing innovative inhaled therapies for rare respirator…
|
AVLN | US | Professional, scientific and te… |
|
Azenta, Inc.
Offers sample management, storage, and multiomics solutions…
|
AZTA | US | Professional, scientific and te… |
|
Baijin Life Science Holdings Limited
An investment holding company operating in biopharmaceutica…
|
1466 | HK | Professional, scientific and te… |
|
BCAL DIAGNOSTICS LIMITED
Developing a non-invasive blood test for early breast cance…
|
BDX | AU | Professional, scientific and te… |
|
BEBETTER MED INC.
Develops small molecule therapeutics for oncology, metaboli…
|
688759 | CN | Professional, scientific and te… |
PROVEXIS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7862/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7862 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7862 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7862 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7862}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PROVEXIS PLC (id: 7862)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.